Skip to main content
Download PDF

Erratum to: JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer

Breast Cancer Research volume 19, Article number: 42 (2017) Cite this article

The Original Article was published on 23 May 2012

Erratum

Main text: After the publication of this work [1] an error was noticed in Fig. 8. In the SMAD2P465/467 panel, the images for MCF-7 and MDA MB 231 cells were accidentally duplicated. The corrected figure is shown below. We apologize for this error, which does not affect the findings or conclusions of the article.

Fig. 8
figure 1

JMJD6 expression affects SMAD phosphorylation. Immunoblots show that the level of total SMAD2/3, phosphorylated SMAD2 and phosphorylated SMAD3 are decreased in MCF-7 J1-OE clones, and increased in JMJD6 siRNA-mediated knock-down in MCF-7 and MDA-MB231. The numbers next to the SMAD2P/3P denote the expected sites of phosphorylation detected by the antibodies. N.S. denotes non-specific bands from the blots which indicate equal loading of the protein lysates

Full size image

Reference

  1. Lee YF, Miller LD, Chan XB, Black MA, Pang B, Ong CW, Salto-Tellez M, Liu ET, Desai KV. JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer. Breast cancer research: BCR. 2012;14(3):R85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clearbridge BioMedics Private Ltd, 81 Science Park Drive, Singapore, Singapore

    Yi Fang Lee & Xiu Bin Chan

  2. Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA

    Lance David Miller

  3. Department of Pathology, National University Health System and National University of Singapore, 5 Lower Kent Ridge Road, Singapore, 119074, Singapore

    Brendan Pang & Chee Wee Ong

  4. Centre for Cancer Research and Cell Biology, Queen’s University Belfast, Belfast, UK

    Manuel Salto-Tellez

  5. Cancer Science Institute, National University of Singapore, 28 Medical Drive, Singapore, 117456, Singapore

    Manuel Salto-Tellez

  6. Department of Biochemistry, Otago School of Medical Sciences, University of Otago, 710 Cumberland Street, Dunedin, 9054, New Zealand

    Michael A. Black

  7. The Jackson Laboratory, Bar Harbor, ME, 04609, USA

    Edison T. Liu

  8. National Institute of Biomedical Genomics, 2 Netaji Subash Sanatorium (T.B. Hospital), Kalyani, 741251, India

    Kartiki V. Desai

Authors
  1. Yi Fang Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lance David Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiu Bin Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael A. Black
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Brendan Pang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Chee Wee Ong
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Manuel Salto-Tellez
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Edison T. Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kartiki V. Desai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kartiki V. Desai.

Additional information

The online version of the original article can be found under doi:10.1186/bcr3200.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, Y.F., Miller, L.D., Chan, X.B. et al. Erratum to: JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer. Breast Cancer Res 19, 42 (2017). https://doi.org/10.1186/s13058-017-0830-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13058-017-0830-9

Breast Cancer Research

ISSN: 1465-542X

Contact us